Over 100 genetic loci harbor schizophrenia associated variants, yet how these common 74 variants confer risk is uncertain. The CommonMind Consortium has sequenced dorsolateral 75 prefrontal cortex RNA from schizophrenia cases (n=258) and control subjects (n=279), creating 76 the largest publicly available resource to date of gene expression and its genetic regulation; ~5 77 times larger than the latest release of GTEx. Using this resource, we find that ~20% of the 78 schizophrenia risk loci have common variants that could explain regulation of brain gene 79 expression. In five loci, these variants modulate expression of a single gene: FURIN, TSNARE1, 80 CNTN4, CLCN3 or SNAP91. Experimentally altered expression of three of them, FURIN, 81 TSNARE1, and CNTN4, perturbs the proliferation and apoptotic index of neural progenitors and 82 leads to neuroanatomical deficits in zebrafish. Furthermore, shRNA mediated knock-down of 83 FURIN in neural progenitor cells derived from human induced pluripotent stem cells produces 84 abnormal neural migration. Although 4.2% of genes (N = 693) display significant differential 85 expression between cases and controls, 44% show some evidence for differential expression.
140
batch effects, multiple randomization steps were introduced and DNA and RNA isolation and 141 library preparation were performed at one site ( Supplementary Fig. 1A ). Samples were 142 genotyped on the Illumina Infinium HumanOmniExpressExome array (958,178 SNPs) and 143 imputed using standard techniques with the 1000 Genomes Project as reference data (21) . Supplementary Fig. 2 ).
156
Following data normalization, 16 ,423 genes (based on Ensembl models) were expressed at 6 and sex together explained a substantial fraction (0.42) of the average variance of gene 165 expression, and were thus employed to adjust the data for all analyses.
167
Generation of a brain eQTL resource 168 To identify eQTLs, gene expression data from European-ancestry subjects (n=467) were 169 adjusted for known and hidden variables detected by surrogate variable analysis (SVA) 170 conditional on diagnosis but excluding ancestry ( Supplementary Fig. 2 and 4 ). Adjusted 171 expression levels were then fit to imputed SNP genotypes, covarying for ancestry and diagnosis, 172 using an additive linear model implemented in MatrixEQTL (22) . The model identified 2,154,331 173 significant cis-eQTLs, (i.e., within 1 Mb of a gene) at a false discovery rate (FDR) ≤ 5%, for 174 13 ,137 (80%) of 16,423 genes. Many eQTLs for the same gene were highly correlated, due to 175 linkage disequilibrium, and 32.8% of eQTL SNPs ("eSNPs") predict expression of more than 176 one gene. Cis-eSNPs were enriched within genic elements and non-coding RNAs, particularly 177 within 100 kb of the transcription start and end sites (23) , and depleted in intergenic regions ( Fig.   178 1A, B). As defined by GTEx (24) , an "eGene" is a gene with at least one significant eSNP after 179 strict correction for multiple marker testing for that gene. There were 8,427 eGenes at FDR ≤ 180 5%, or 18 eGenes discovered per sample, consistent with a prediction from GTEx. We 181 examined the enrichment of max-eQTLs (defined as the most significant eSNP per gene, if any) 182 in predicted enhancer sequences derived from the Roadmap Epigenomics Consortium and 183 ENCODE across 98 human tissues and cell lines (25) . Cis-eQTLs were enriched for enhancer 184 sequences present in brain tissues (Kolmogorov-Smirnov (KS) test versus non-brain: D = 1, p = 185 4 .5 x 10 -6 ), and the strongest enrichment is observed in DLPFC enhancers (Z = 9.5) (Fig. 1C ).
187
To assess the utility of our much larger brain dataset, we compared previously reported 188 DLPFC eQTLs to CMC-derived eQTL, estimating the proportion of non-null hypotheses (π 1 ) in 189 CMC (26) and the number of additional eQTL found in CMC that were not detected in the other 190 studies. GTEx v6 is the largest public dataset of eQTLs from DLPFC tissue (n = 92) assayed by 191 RNA-seq; its replication in CMC is π 1 = 0.98. Considering microarray-based eQTLs from the 192 Harvard Brain Bank (27) , BrainCloud (28) , NIH (29) , and the UK Brain Expression Consortium 193 (UKBEC) (30), we estimated π 1 to be 0.75, 0.70, 0.79, and 0.93, respectively, indicating that our 194 results captured most eQTLs found in other independent samples. Replication was somewhat 195 lower for a recent meta-analysis that included mixed several distinct brain regions (31) (π 1 = 196 0.62), and for eQTLs detected in blood (π 1 = 0.54) (32) . We also derived eQTL for 279 DLPFC 197 samples as part of the NIMH Human Brain Collection Core (HBCC) microarray data and found 198 replication π 1 = 0.77. Moreover, concordance of the direction of allelic effect was high, with 93% 199 of eQTL showing the same direction of effect when intersecting CMC eQTL (FDR ≤ 5%) with 7 even a liberally defined set of HBCC eQTL (FDR ≤ 20%). In addition to containing the vast 201 majority of eQTL found in the literature, the CMC sample finds a substantial number of genes 202 with previously undetected eQTL (Table 1) .
204
The patterns of results should be different for "trans-eQTLs", i.e., SNPs correlated with 205 expression of a gene beyond 1 Mb of its genomic location. Trans-eQTLs incur a greater penalty 206 for multiple testing, require greater power for detection, and are thus more susceptible to false 207 positives and less likely to replicate than cis-eQTL. Nevertheless, the data supported 45,453 208 significant trans-eQTL at FDR ≤ 5%, of which 20,288 were also cis-eQTL SNPs for local genes, 209 and 34% predicted expression of more than one distant gene. The proportion of trans eQTL in 210 CMC that replicate in HBCC is 18.6% (both FDR ≤ 5%). The proportion of HBCC trans eQTL 211 that replicate in CMC is 29.7%. Enrichment of trans-eQTLs with brain enhancers was not 212 observed (data not shown), though enrichment in genic regions and depletion in intergenic 213 regions was observed, particularly when restricting to trans eQTL ≥ 10 Mb from the gene 214 location. We used similar techniques to derive isoform expression quantitative trait loci 215 (isoQTLs). Those results are described in Supplementary Information. 216 217 eQTL signatures at SCZ risk loci point to specific genes 218 A hallmark of polygenic inheritance is that individual SNPs confer small effects on risk.
219
For some risk SNPs, perhaps the majority, their impact could be mediated through effects on 220 gene expression. Indeed, GWAS SNPs associated with SCZ risk occur more often than 221 expected by chance in cis-regulatory functional genomic elements, such as enhancers or eQTL 222 SNPs (7, (33) (34) (35) . Yet, GWAS loci typically contain many genes, and SNPs therein are often 223 highly correlated via linkage disequilibrium, so that assigning a biological role for a particular risk 224 SNP has been difficult. Here, we leverage CMC-derived eQTL to relate SCZ risk variants to 225 expression of specific genes.
227
Of the 108 SCZ GWAS loci previously reported (7) , 73 harbor cis-eQTL SNPs for one or 228 more genes (FDR ≤ 5%). However, the simple presence of an eQTL does not imply disease 229 causality (36) . We used Sherlock (37), a Bayesian approach that prioritizes consistency 230 between disease association and eQTL signatures in GWAS loci, to identify genes likely to 231 contribute to SCZ etiology. While Sherlock evaluated genes across the genome, we only 232 evaluated genes within the 108 SCZ GWAS loci because SNPs in these loci showed genome-233 wide significant association with SCZ; thus, in essence, we fine mapped these loci. The results 234 suggested that GWAS risk and eQTL association signals co-localized for 84 genes in 30 of 8 additional evaluation indicated lack of consistency ( Supplementary Fig. 6B ), there were 33 237 genes highlighted in 18 of the 108 GWAS loci (data file 2). Genes found to have variants 238 affecting risk for autism are often found enriched for variation affecting risk for SCZ; indeed, 239 compared to other genes with eQTL in the GWAS loci, these 33 genes are more enriched for 240 nonsynonymous de novo mutations in autism (fold enrichment = 2.4, p corrected = 0.03), although 241 not for SCZ, intellectual disability, or epilepsy.
242
Repeating the analyses using isoform-level eQTLs (isoQTL) identified nine genes in 243 eight GWAS loci, with all but three genes already identified in the gene-level analysis (data file (38) , with unpublished human DLPFC RNA 259 sequencing data (n=461). The most significant GWAS SNP was also a significant eQTL with the 260 same direction of effect as in CMC for FURIN (rs4702: p = 1 x 10 -6 ), CLCN3 (rs10520163: p = 9 261 x 10 -6 ), and SNAP91 (rs3798869: p = 3 x 10 -4 ); TSNARE1 (rs4129585: p = 0.057) and CNTN4 262 (rs17194490: p = 0.07) also had alleles in the same direction of effect as in CMC but did not (40) . It plays a key role in olfactory axon guidance (41) , and 274 there is evidence for association of copy number variants overlapping CNTN4 with autism (42) .
275
FURIN processes precursor proteins to mature forms, including brain-derived neurotrophic 276 factor (BDNF) (43, 44) , a key molecule in brain development whose down-modulation has been 277 hypothesized as related to schizophrenia (45) , and BDNF and FURIN are up-regulated in 278 astrocytes in response to stress (43) . 
292
Our results point to a number of genes worthy of follow-up, and we sought an assay that 293 was rapid and amenable to over-and under-expression. Manipulation of zebrafish embryos fits 294 these requirements, especially for evaluation of anatomical phenotypes of early development, 295 such as head and brain size (or area). Perturbing expression of one or more genes in zebrafish 296 has been used to identify genes contributing to neuropsychiatric disorders (47) (48) (49) . Therefore, 297 we asked whether suppression or overexpression of the corresponding gene within each of the 298 five SCZ risk loci could identify key proteins that regulate brain development. To evaluate the 299 four genes up-regulated by risk alleles in the GWAS loci, we injected 200pg of human capped 300 mRNA encoding TSNARE1, CNTN4, SNAP91, or CLCN3 in 1-8 cell stage embryos (n = 60 per 301 experiment, at least two biological replicates performed). At 3 days post-fertilization (dpf), we 302 assessed the area of the head that contains the forebrain and midbrain structures ( Fig. 3A, B ).
303
Relative to control embryos, overexpression of TSNARE1 or CNTN4 resulted in a significant 304 decrease in head size, 9.5% (p < 0.001) and 3.5% (p = 0.018), respectively, while SNAP91 or 305 CLCN3 showed no statistically significant effect (Fig. 3A, B ). Body length and somitic structures 306 were similar across all embryos, suggesting that our observations were unlikely due to gross 10 human brains associated with SCZ risk. A reciprocal BLAST search of the zebrafish genome 309 revealed a FURIN ortholog with two potential paralogs; both copies were expressed at ~40-60 310 counts per million reads in mRNA from heads of 3 dpf zebrafish embryos (50) . We depleted 311 furin_a, the isoform most closely resembling the human ortholog, using a splice blocking 312 morpholino (sbMO) that almost completely extinguished expression of the endogenous 313 message by triggering the inclusion of intron 7 ( Supplementary Fig. 7 ). Suppression of furin_a 314 led to a 24% decrease in head size (Fig. 3A, B) ; this observation was replicated with a second 315 sbMO targeting exon 5 (data not shown). Importantly, expression of human FURIN mRNA could 316 rescue the phenotype induced by either morpholino, providing evidence for specificity 317 ( Supplementary Fig. 7E ).
319
Given a potential role for FURIN, TSNARE1, and CNTN4 during neurogenesis, we 320 asked whether the decrease in head size could be attributed to changes in cell proliferation 321 and/or apoptosis. Overexpression of CNTN4 and suppression of furin_a led to a 9.8% (p = 322 0.003) and a 29.8% (p < 0.001) decrease, respectively, in proliferating cells marked by 323 phospho-histone3 (PH3), and overexpression of TSNARE1 led to a 9.5% increase (p = 0.018) in 
359
As expected, hierarchical clustering of the differentially expressed genes showed case-control 360 distinctions but were independent of institution, sex, age at death, ethnicity, and RIN ( Fig. 5A ).
361
We examined differential expression in an independent sample, the NIMH Human Brain 362 Collection Core (HBCC), which generated DLPFC gene expression data using Illumina 363 HumanHT-12_V4 Beadchip microarrays from 131 SCZ cases and 176 controls. Though these 364 arrays differ from RNA-seq in their capture features, there was high correlation of test statistics 365 for differential expression in CMC compared to HBCC for the differentially expressed genes also 366 present in the HBCC data (480 of 693), Pearson correlation r = 0.58 (p < 10 -16 ); the correlation 367 remains high (r = 0.28, p < 10 -16 ) across all 10,928 genes common to both platforms after QC 368 ( Fig. 5C ).
370
The differential expression observed here is smaller than that reported in earlier studies 371 (data file 1), but it is consistent with plausible models for average differential gene expression 372 and the polygenic inheritance of SCZ (Supplementary Text, with meta-analysis of earlier studies 373 Supplementary Fig. 8 ). Consider, for example, a gene for which the major determinant of 374 differential expression is the case-control difference in allele frequency at an eQTL SNP. For 375 that gene, the expected magnitude of differential expression fold change will be on the order of 376 the allele frequency differences seen in the recent large Psychiatric Genomic Consortium SCZ 12 genetic association study (~1-2%) (7) , precisely what is observed in the CMC data. Such 378 modeling can also explain the difference between earlier studies and CMC results; because 379 earlier studies tend to be far smaller in sample size, their larger differential expression is 380 consistent with either the well-known "Winner's Curse" (57) or false positives that may occur in 381 smaller samples. Finally, our results imply a need for thousands of samples to ensure 80% 382 statistical power to observe differential expression between cases and controls for the genes 383 implicated at SCZ-associated eQTL, e.g., the five genes of interest above.
385
The most highly up-regulated protein-coding gene is tachykinin receptor 3 (TACR3, NK 3 386 receptor, 1.24-fold, Fig. 5D ). NK3 antagonists have been tested in SCZ and other CNS diseases 387 (58) . Moreover, rat and human studies have suggested a role for the NK 3 receptor in memory 388 and cognition (59), both key impairments of schizophrenia (60) . Insulin-like growth factor 2 389 (IGF2), the most strongly down-regulated gene (1.33-fold, Fig. 5D ), can rescue neurogenesis 390 and cognitive deficits in certain mouse models of schizophrenia (61) . Also included among the 391 top 100 differentially expressed genes are the alpha 5 subunit of the GABA A receptor 392 (GABRA5) (62) and calbindin (CALB1) (63), genes previously reported as differentially 393 expressed in cortical tissue from schizophrenia patients, suggesting GABAergic interneuron 394 dysfunction (64).
396
We identified 239 isoforms differentially expressed between SCZ cases and controls: 94 397 up-regulated and 145 down-regulated. These isoforms derive from 223 genes, which are 398 enriched, as expected, for overlap with the 693 differentially expressed genes (p = 2 x 10 -131 ,
399
Fisher's exact test), and 136 are differentially expressed at both the gene and isoform levels 400 ( Supplementary Fig. 9 ). No obvious unifying biological theme emerges from this set of genes 401 and isoforms on the basis of pathway enrichment analysis (data file 4). An assessment of the 402 impact of age at death or cell type proportions suggests that these variables do not explain 403 significant differential expression ( Supplementary Fig. 10 ). Although analyses of experiments 404 performed using either monkeys or rodents indicate that genes whose expression are affected 405 by antipsychotics are often the same as those we find altered in individuals with SCZ, the 406 impact of antipsychotic drugs nevertheless tends to be significantly in the opposite direction of 407 that observed in the SCZ subjects ( Supplementary Table 2 ). Thus, our analyses find that genes 408 highlighted by the contrast of SCZ cases versus control subjects do not largely trace their 409 differential expression to antipsychotic medications, although intriguingly they do suggest a 410 mechanism for the efficacy of these drugs (65). 13 Coordinated expression of genes is critical to brain development and function. One 414 expectation of polygenic inheritance of disease is that this coordination may be subtly altered in 415 individuals with SCZ. To assess this, we applied weighted gene co-expression network analysis 416 (WGCNA) (66) to the matrix of pairwise gene co-expression values. WGCNA recovers a 417 network that consists of nodes (genes) and edges connecting nodes (i.e., the degree of co-418 expression for a pair of genes, measured as their correlation after transformation by raising the 419 value to a power β that results in an overall scale-free topology). WGCNA divides the network 420 into subnetworks called modules, or clusters of genes with more highly correlated expression.
422
We constructed gene co-expression networks separately from control individuals and 423 SCZ cases (data file 5), since we wished to assess disease-dependent changes in co-424 expression for modules of interest (27) . The co-expression network generated from the controls 425 consisted of 35 modules each containing between 30 and 1,900 genes, along with ~3,600 426 unclustered genes (data file S5). Four modules stand out in harboring an excess of differentially 427 expressed genes (Fig. 6A , data file 6). Of these, however, only one (M2c) shows association 428 with differential expression (OR = 2.3, p = 1 x 10 -13 ) and multiple prior genetic associations with 429 SCZ; the latter encompasses genes in GWAS loci (FE [fold-enrichment] = 1.36, p = 0.04), rare 430 CNV (FE = 1.52, p = 0.051), and rare nonsynonymous variants (FE = 1.18, p = 2 x 10 -4 ) 431 (Supplementary table 3 ). Given its apparent relevance to SCZ risk, we tested if the co-432 expression pattern for M2c was perturbed in SCZ samples relative to controls. We used two 433 categories of network-based preservation statistics: (a) testing whether highly connected nodes 434 in a module remain as highly connected ("density"), or (b) testing for differences in the overall 435 connectivity pattern in a module ("connectivity"). The M2c module exhibits a loss of density in 436 the SCZ cases (permutation Z = -1.79, one-tailed p = 0.037, Fig. 6B ) but no loss of connectivity.
437
The loss of density replicates in the HBCC cohort (Z = -3.02, p = 0.003), indicating that the 438 regulatory coordination of genes in this module is disrupted in SCZ. The dysregulation of M2c in 439 SCZ is not due to medication effect or clinical and technical confounds (See Supplement).
441
Consistent with prior studies of the brain transcriptome (27, (67) (68) (69) (70) , we find gene co-442 expression to be organized into modules of distinct cellular and functional categories (data file Bonferroni multiple test correction for other gene sets using standard approaches. Gene co-511 expression networks were constructed using WCGNA separately for schizophrenia cases and 512 controls, co-expression modules were extracted, and case and control modules were contrasted 513 for differential co-expression using a permutation-based approach. Module genes were tested 514 for enrichment in disease genetics and other gene sets. 
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